Marc Boutin, who is leading the Patient Engagement activities of Novartis, and Laura McKeaveney, his predecessor, sat down to talk with Monocle to discuss the strategic and operational importance of listening to patients and understanding their needs. Boutin and McKeaveney aim to translate these insights to help develop drugs that ultimately help patients improve their quality of life.

Published on 22/03/2021